US private equity firm Carlyle Group has exited its 10.2% stake in digital healthcare services provider Indegene for Rs 1,447 crore.
Top buyers of Indegene shares after Carlyle's exit include Premji Invest's affiliate, Capital Group, Societe Generale, Eastbridge Group, and Abakkus Asset Manager.
The shares were purchased in the price range of Rs 591-591.48 apiece, with East Bridge Capital Master Fund I, Societe Generale, and Capital Group's Small Cap World Fund making significant investments.
Following these transactions, Indegene's stock closed 4% lower at Rs 594.5 on the NSE, with analysts providing mixed recommendations on the company.